Kenosha, WI, United States of America

Calvin L Becker

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Abbvie Inc.. Active years: 2015-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Calvin L Becker. Retrieved from https://idiyas.com/inventor/calvin-l-becker

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Calvin L Becker: Innovator in Antiviral Compounds

Introduction

Calvin L Becker is an accomplished inventor based in the United States. He has made significant contributions to the field of antiviral compounds, particularly in the fight against hepatitis C virus (HCV). His innovative work focuses on processes for preparing substituted pyrimidine antiviral compounds.

Latest Patents

Calvin L Becker holds a notable patent titled "Process For Preparing Substituted Pyrimidine Antiviral Compound." This invention is directed to processes for preparing a compound and salts that are useful for inhibiting HCV. The patent also covers intermediates useful for the preparation of the compound and salts, pharmaceutical compositions comprising the compound or salts, and methods of use of such compositions.

Career Highlights

Calvin L Becker is currently employed at AbbVie Bahamas Limited, where he continues to advance his research in antiviral therapies. His work has the potential to impact the treatment of HCV significantly.

Collaborations

Calvin collaborates with Jean-Christophe C Califano, contributing to the development of innovative antiviral solutions.

Conclusion

Calvin L Becker's contributions to antiviral research highlight his dedication to improving healthcare outcomes. His work in developing processes for antiviral compounds is crucial in the ongoing battle against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…